|
Jan 4
|
Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO
|
|
Jan 3
|
C4 Therapeutics (CCCC) Gains 310% in 3 Months: Here's Why
|
|
Jan 3
|
Anavex (AVXL) Falls 35% on Mixed Rett Syndrome Study Results
|
|
Jan 3
|
Longboard Pharma (LBPH) Up on Upbeat Data From Epilepsy Study
|
|
Jan 2
|
Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva
|
|
Dec 29
|
Amicus (FOLD) Banks on Galafold, Overdependence a Concern
|
|
Dec 28
|
Iovance (IOVA) Falls After Clinical Update on Lung Cancer Drug
|
|
Dec 28
|
Coherus (CHRS) Stock Rallies on FDA Nod for Udenyca Onbody
|
|
Dec 26
|
Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate
|
|
Dec 26
|
Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis
|
|
Dec 22
|
Sanofi (SNY) Discontinues Tusamitamab Ravtansine Cancer Program
|
|
Dec 21
|
argenx (ARGX) Tanks on Top-Line Data From Pemphigus Study
|
|
Dec 20
|
Roche's (RHHBY) sBLA for Xolair Gets FDA Priority Review Tag
|
|
Dec 20
|
Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA
|
|
Dec 19
|
Invivyd (IVVD) Surges on Positive Data From COVID-19 Study
|
|
Dec 8
|
With 39% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors
|
|
Dec 8
|
Kymera (KYMR) Rises as Dosing Begins in AD Study on KT-474
|
|
Dec 7
|
Syros (SYRS) Rises on Upbeat Initial Study Data on Tamibarotene
|
|
Dec 5
|
Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
|
|
Dec 1
|
AstraZeneca (AZN) to Discontinue Two Studies on Lokelma
|